Royal Bank of Canada reaffirmed their outperform rating on shares of agilon health ( NYSE:AGL – Free Report ) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $3.00 price objective on the stock.
Other research analysts have also issued reports about the stock. Stifel Nicolaus decreased their price target on shares of agilon health from $7.00 to $2.
00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Barclays decreased their price target on shares of agilon health from $5.00 to $2.
00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Citigroup decreased their price target on shares of agilon health from $2.50 to $1.
75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.
00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company.
Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $6.05. Read Our Latest Research Report on AGL agilon health Trading Up 6.
2 % agilon health ( NYSE:AGL – Get Free Report ) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.
10) by ($0.19). agilon health had a negative return on equity of 47.
84% and a negative net margin of 6.88%. The firm had revenue of $1.
45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the previous year, the company earned ($0.
06) earnings per share. As a group, equities analysts forecast that agilon health will post -0.47 EPS for the current fiscal year.
Insider Transactions at agilon health In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.
00. Following the transaction, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40.
This trade represents a 42.03 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website .
Insiders own 3.20% of the company’s stock. Hedge Funds Weigh In On agilon health Hedge funds have recently made changes to their positions in the stock.
Capital International Investors boosted its position in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after buying an additional 9,263,296 shares during the period.
Citigroup Inc. boosted its position in agilon health by 2,251.5% in the 3rd quarter.
Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its position in agilon health by 3,338.
5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Quantbot Technologies LP purchased a new position in agilon health in the 3rd quarter valued at approximately $1,742,000.
Finally, Vanguard Group Inc. boosted its position in agilon health by 1.3% in the 1st quarter.
Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period. About agilon health ( Get Free Report ) agilon health, inc.
provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter ..
Business
Royal Bank of Canada Reiterates “Outperform” Rating for agilon health (NYSE:AGL)
Royal Bank of Canada reaffirmed their outperform rating on shares of agilon health (NYSE:AGL – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $3.00 price objective on the stock. Other research analysts have also issued reports about the stock. Stifel Nicolaus decreased their price target [...]